These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 9777103

  • 1. [New fluoroquinolones: characteristics of antimicrobial effect and pharmacokinetics].
    Bondareva NS, Budanov SV.
    Antibiot Khimioter; 1998; 43(8):28-33. PubMed ID: 9777103
    [No Abstract] [Full Text] [Related]

  • 2. [Moxifloxacin--antimicrobial activity and pharmacokinetic properties].
    Iakovlev VP, Polushkina NR.
    Antibiot Khimioter; 2002; 47(5):19-29. PubMed ID: 12365324
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects.
    Gootz TD, Brighty KE.
    Med Res Rev; 1996 Sep; 16(5):433-86. PubMed ID: 8865150
    [No Abstract] [Full Text] [Related]

  • 5. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M, Coll R, Esteve M, Parés J, Xicota MA.
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fluoroquinolones.
    O'Donnell JA, Gelone SP.
    Infect Dis Clin North Am; 2000 Jun; 14(2):489-513, xi. PubMed ID: 10829268
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone.
    Park HS, Kim HJ, Seol MJ, Choi DR, Choi EC, Kwak JH.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2261-4. PubMed ID: 16723601
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT, Farinelli S, Iegri F, Iona E, De Simone C.
    Drugs Exp Clin Res; 1998 Jun; 24(3):139-51. PubMed ID: 9825230
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
    Barry AL, Fuchs PC, Brown SD.
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
    [Abstract] [Full Text] [Related]

  • 14. Gaps and perspectives of new fluoroquinolones.
    Neuman M, Esanu A.
    Drugs Exp Clin Res; 1988 Jun; 14(6):385-91. PubMed ID: 3215107
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH, Wang JT, Chen YC, Chang SC, Luh KT.
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and antimicrobial activity of 1,3,4-triaryl-2-azetidinones.
    Diurno MV, Mazzoni O, Piscopo E, Bolognese A.
    Farmaco; 1992 Feb; 47(2):239-47. PubMed ID: 1510796
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antimicrobial activity of enoxacin.
    Nicoletti G, Caccamo F, Speciale A.
    J Chemother; 1989 Jul; 1(4 Suppl):143-4. PubMed ID: 16312344
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.